Arginine

Arginine

SCHEMBL2485034

N=C(N)NCCC[C@H](N)C(=O)O.Nc1ccccc1C(=O)O

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACE

The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
OTC P00480 1/20 0.40
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
DDAH1 O94760 1/20 0.38
CASR P41180 1/20 0.38
KYNU Q16719 2/20 0.37
KIF11 P52732 3/20 0.37
HTT P42858 1/20 0.36
MAPK14 Q16539 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arginine SCHEMBL4728793 1.00 OTC (0.40) OTCPOLBKMT2ATDP1DDAH1
Arginine SCHEMBL5606089 0.88 ALDH1A1 (0.45) OTCPOLBKMT2ATDP1DDAH1
Arginine SCHEMBL4208935 0.88 ALDH1A1 (0.45) OTCPOLBKMT2ATDP1DDAH1
Arginine SCHEMBL28111285 0.85 OTC (0.39) OTCPOLBKMT2ATDP1DDAH1
Arginine SCHEMBL12006798 0.84 OTC (0.43) OTCPOLBKMT2ATDP1DDAH1
Arginine SCHEMBL1287134 0.84 OTC (0.43) OTCPOLBKMT2ATDP1DDAH1
Arginine SCHEMBL8525152 0.84 ALDH1A1 (0.41) OTCPOLBKMT2ATDP1DDAH1
Arginine SCHEMBL28268971 0.84 OTC (0.53) OTCKMT2ADDAH1
Arginine SCHEMBL28911625 0.83 OTC (0.43) OTCPOLBKMT2ATDP1DDAH1
Arginine SCHEMBL26914670 0.83 KIF11 (0.46) OTCPOLBKMT2ATDP1DDAH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11633452-B2 Compositions and methods for treating vaginal dryness THE PROCTER & GAMBLE COMPANY (US) 2023-04-25 US claimed
EP-3787656-A1 COMPOSITIONS AND METHODS FOR TREATING VAGINAL DRYNESS The Procter & Gamble Company (US) 2021-03-10 EP claimed
US-20210038679-A1 COMPOSITIONS AND METHODS FOR TREATING VAGINAL DRYNESS THE PROCTER & GAMBLE COMPANY 2021-02-11 US claimed
CN-112088010-A Compositions and methods for treating vaginal dryness 宝洁公司 2020-12-15 CN claimed
US-20170304187-A1 EMU Oil In Combination With Other Active Ingredients For Treating Skin Imperfections DESAI, KETAN 2017-10-26 US claimed
US-11633452-B2 Compositions and methods for treating vaginal dryness THE PROCTER & GAMBLE COMPANY (US) 2023-04-25 US disclosed
US-20220409518-A1 EMU Oil In Combination With Other Active Ingredients For Treating Skin Imperfections DESAI, KETAN 2022-12-29 US disclosed
EP-3787656-A1 COMPOSITIONS AND METHODS FOR TREATING VAGINAL DRYNESS The Procter & Gamble Company (US) 2021-03-10 EP disclosed
US-20210038679-A1 COMPOSITIONS AND METHODS FOR TREATING VAGINAL DRYNESS THE PROCTER & GAMBLE COMPANY 2021-02-11 US disclosed
CN-112088010-A Compositions and methods for treating vaginal dryness 宝洁公司 2020-12-15 CN disclosed
EP-3366274-A1 COSMETIC BIOPHOTONIC COMPOSITIONS KLOX Technologies, Inc. (CA) 2018-08-29 EP disclosed
US-20170326378-A1 COSMETIC BIOPHOTONIC COMPOSITIONS KLOX TECHNOLOGIES INC. (CA) 2017-11-16 US disclosed
WO-2001001933-A2 PRE-FORMED, SELF-ADHESIVE SHEET DEVICES SUITABLE FOR TOPICAL APPLICATION THE PROCTER & GAMBLE COMPANY (US) 2001-01-11 WO disclosed
WO-2001001951-A1 SHEET-LIKE DEVICES THE PROCTER & GAMBLE COMPANY (US) 2001-01-11 WO disclosed
WO-2001002028-A2 PRE-FORMED, SHEET DEVICES SUITABLE FOR TOPICAL APPLICATION THE PROCTER & GAMBLE COMPANY (US) 2001-01-11 WO disclosed
WO-2001002477-A1 PRE-FORMED, SELF-ADHESIVE SHEETS SUITABLE FOR TOPICAL APPLICATION THE PROCTER & GAMBLE COMPANY (US) 2001-01-11 WO disclosed
WO-2001001952-A1 DEVICES THE PROCTER & GAMBLE COMPANY (US) 2001-01-11 WO disclosed
WO-2001001816-A1 COSMETIC OR DERMAPHARMACEUTICAL PATCH PROCTER & GAMBLE COMPANY (US) 2001-01-11 WO disclosed
US-5734080-A SKIN DISORDERS; WOUND HEALING AGENT ANIHEALTH CORPORATION (US) 1998-03-31 US disclosed
WO-1997010830-A1 REACTION PRODUCT OF ARGININE AND p-AMINOBENZOIC ACID SCHUTT STEVEN R (US) 1997-03-27 WO disclosed